New Vernon Investment Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,165
Closed -$564K 34
2023
Q2
$564K Hold
8,165
0.91% 24
2023
Q1
$607K Hold
8,165
1.25% 20
2022
Q4
$761K Hold
8,165
1.17% 18
2022
Q3
$779K Hold
8,165
1.59% 16
2022
Q2
$757K Hold
8,165
1.3% 19
2022
Q1
$826K Hold
8,165
1.15% 18
2021
Q4
$842K Hold
8,165
1.35% 17
2021
Q3
$693K Hold
8,165
1.18% 22
2021
Q2
$681K Hold
8,165
1.14% 23
2021
Q1
$614K Hold
8,165
1.02% 28
2020
Q4
$558K Hold
8,165
1.06% 27
2020
Q3
$477K Hold
8,165
1.07% 30
2020
Q2
$530K Hold
8,165
1.33% 23
2020
Q1
$484K Hold
8,165
1.26% 21
2019
Q4
$607K Hold
8,165
1.29% 18
2019
Q3
$515K Hold
8,165
1.08% 23
2019
Q2
$445K Hold
8,165
0.88% 36
2019
Q1
$440K Buy
8,165
+1,765
+28% +$109K 1.06% 34
2018
Q4
$419K Buy
6,400
+225
+4% +$16.8K 1.21% 17
2018
Q3
$486K Hold
6,175
0.58% 49
2018
Q2
$397K Hold
6,175
0.45% 44
2018
Q1
$384K Hold
6,175
0.46% 46
2017
Q4
$448K Hold
6,175
0.47% 45
2017
Q3
$502K Hold
6,175
0.56% 42
2017
Q2
$497K Hold
6,175
0.63% 42
2017
Q1
$485K Buy
+6,175
New +$493K 0.63% 44

Other funds holding CVS

New Vernon Investment Management's CVS Position: Q3 2023 in Review

New Vernon Investment Management sold out of CVS Health (CVS) in Q3 2023, closing a stake of 8,165 shares — an estimated $564K sold.

New Vernon Investment Management first reported a position in CVS in Q1 2017 and held it in 26 quarters. The position peaked at $842K in Q4 2021. 2,114 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • New Vernon Investment Management reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
  • New Vernon Investment Management sold 8,165 CVS Health shares in Q3 2023, an estimated $564K.
  • New Vernon Investment Management first reported a position in CVS Health in Q1 2017 and held it in 26 quarters.
  • New Vernon Investment Management's CVS Health position peaked at $842K in Q4 2021.
  • 2,114 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on New Vernon Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.